Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2025	Sep. 30, 2024
Current Assets
Cash and cash equivalents	$ 162.8	$ 199.3
Trade receivables, net	291.7	350.1
Receivables from long-term manufacturing contracts, net	288.5	302.7
Inventories, net	386.2	525.2
Prepaid expenses and other current assets	157.1	132.6
Total current assets	1,286.3	1,509.9
Property, plant, and equipment, net	246.0	316.6
Operating lease right-of-use assets, net	103.0	168.7
Intangible assets, net	1,158.9	1,285.9
Goodwill	1,685.0	1,835.7
Equity method investments	84.6	9.4
Other long-term assets	112.7	112.5
Total Assets	4,676.5	5,238.7
Current Liabilities
Trade accounts payable	387.8	444.8
Liabilities from long-term manufacturing contracts and advances	255.5	315.2
Current portion of long-term debt	12.6	20.6
Accrued compensation	101.0	122.0
Other current liabilities	273.2	286.5
Total current liabilities	1,030.1	1,189.1
Long-term debt	1,663.6	1,872.4
Accrued pension and postretirement healthcare	90.4	109.3
Operating lease liabilities	78.1	141.1
Deferred income taxes	287.6	314.3
Other long-term liabilities	174.5	155.1
Total Liabilities	3,324.3	3,781.3
Commitments and contingencies (Note 14)
SHAREHOLDERS’ EQUITY
Common stock, no par value (75.8 and 75.8 shares issued, 70.4 and 70.2 shares outstanding)	0.0	0.0
Additional paid-in capital	716.2	712.6
Retained earnings	964.2	1,045.2
Treasury stock (5400000 and 5600000 shares, at cost)	(228.8)	(238.2)
Accumulated other comprehensive loss	(135.1)	(96.6)
Hillenbrand Shareholders’ Equity	1,316.5	1,423.0
Noncontrolling interests	35.7	34.4
Total Shareholders’ Equity	1,352.2	1,457.4
Total Liabilities and Shareholders’ Equity	$ 4,676.5	$ 5,238.7